Lynx1 Capital Management LP Diversified Active

CIK: 0001910456 · Show all filings

Period: Q1 2023 (← Previous) (Next →)

Filing Date: May 15, 2023

Total Value ($000): $119,949 (100.0% shares, 0.0% debt)

Holdings (13)

— ALPINE IMMUNE SCIENCES INC 20.2%

Value ($000) $24,211 Shares 3,136,173 Est. Cost $10.20 Unrealized —

CABA CABALETTA BIO INC 16.9%

Value ($000) $20,300 Shares 2,454,627 Est. Cost $3.64 Unrealized +157.1%

— MERUS N V 16.4%

Value ($000) $19,646 Shares 1,067,723 Est. Cost $24.53 Unrealized —

— KINNATE BIOPHARMA INC 11.5%

Value ($000) $13,839 Shares 2,214,250 Est. Cost $10.62 Unrealized —

— CYMABAY THERAPEUTICS INC 10.0%

Value ($000) $11,946 Shares 1,369,927 Est. Cost $3.16 Unrealized —

— PIERIS PHARMACEUTICALS INC 5.8%

Value ($000) $6,898 Shares 7,067,718 Est. Cost $1.64 Unrealized —

— THESEUS PHARMACEUTICALS INC 5.6%

Value ($000) $6,760 Shares 761,258 Est. Cost $8.59 Unrealized —

— BELLUS HEALTH INC NEW 5.2%

Value ($000) $6,240 Shares 866,646 Est. Cost $7.70 Unrealized —

— PARDES BIOSCIENCES INC 3.7%

Value ($000) $4,388 Shares 3,324,061 Est. Cost $5.72 Unrealized —

— PASSAGE BIO INC 2.7%

Value ($000) $3,263 Shares 3,407,598 Est. Cost $1.43 Unrealized —

— NEOLEUKIN THERAPEUTICS INC 1.4%

Value ($000) $1,700 Shares 2,428,323 Est. Cost $0.52 Unrealized —

GPCR STRUCTURE THERAPEUTICS INC 0.5%

Value ($000) $547 Shares 23,000 Est. Cost $23.79 Unrealized —

PHVS PHARVARIS N V 0.2%

Value ($000) $211 Shares 26,225 Est. Cost $5.38 Unrealized +63.7%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	ALPINE IMMUNE SCIENCES INC	3,136,173	$24,211	20.2%	$10.20	—	COM	02083G100
CABA	CABALETTA BIO INC	2,454,627	$20,300	16.9%	$3.64	+157.1%	COM	12674W109
—	MERUS N V	1,067,723	$19,646	16.4%	$24.53	—	COM	N5749R100
—	KINNATE BIOPHARMA INC	2,214,250	$13,839	11.5%	$10.62	—	COM	49705R105
—	CYMABAY THERAPEUTICS INC	1,369,927	$11,946	10.0%	$3.16	—	COM	23257D103
—	PIERIS PHARMACEUTICALS INC	7,067,718	$6,898	5.8%	$1.64	—	COM	720795103
—	THESEUS PHARMACEUTICALS INC	761,258	$6,760	5.6%	$8.59	—	COM	88369M101
—	BELLUS HEALTH INC NEW	866,646	$6,240	5.2%	$7.70	—	COM NEW	07987C204
—	PARDES BIOSCIENCES INC	3,324,061	$4,388	3.7%	$5.72	—	COM	69945Q105
—	PASSAGE BIO INC	3,407,598	$3,263	2.7%	$1.43	—	COM	702712100
—	NEOLEUKIN THERAPEUTICS INC	2,428,323	$1,700	1.4%	$0.52	—	COM	64049K104
GPCR	STRUCTURE THERAPEUTICS INC	23,000	$547	0.5%	$23.79	—	SPONSORED ADS	86366E106
PHVS	PHARVARIS N V	26,225	$211	0.2%	$5.38	+63.7%	COM	N69605108